What is the treatment for esophageal varices?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Esophageal Varices

The treatment of esophageal varices requires a combination of pharmacological therapy with vasoactive agents and endoscopic band ligation, with transjugular intrahepatic portosystemic shunt (TIPS) reserved for treatment failures. 1, 2

Acute Variceal Bleeding Management

Initial Management

  1. Resuscitation and Medical Therapy

    • Initiate vasoactive agents immediately upon suspicion of variceal bleeding (terlipressin, octreotide, or somatostatin) and continue for up to 5 days 2
    • Use restrictive blood transfusion strategy (hemoglobin threshold ≤70 g/L) 2
    • Administer prophylactic antibiotics (ceftriaxone 1g/day for up to 7 days) 2
    • Consider IV erythromycin 250mg 30-120 minutes before endoscopy 2
  2. Endoscopic Management

    • Perform endoscopy within 12 hours of presentation after hemodynamic stabilization 2
    • Endoscopic variceal ligation (EVL) is the preferred first-line endoscopic treatment for acute esophageal variceal bleeding 1, 2
    • For gastric varices:
      • GOV1 (gastroesophageal varices type 1): EVL or cyanoacrylate injection 2
      • GOV2/IGV1 (isolated gastric varices): Cyanoacrylate injection 2
  3. Management of Treatment Failure

    • For persistent bleeding despite pharmacological and endoscopic therapy, urgent rescue TIPS should be considered 2
    • Self-expanding metal stents or balloon tamponade can be used as bridge therapy when TIPS is not immediately available 1, 3

Prevention of Recurrent Bleeding (Secondary Prophylaxis)

  1. Combination Therapy

    • Combination of non-selective beta-blockers (NSBBs) plus EVL is the best option for secondary prophylaxis 1, 2
    • Adjust beta-blocker to maximal tolerated dose 1
    • Carvedilol or propranolol are recommended NSBBs 2
  2. Endoscopic Follow-up

    • Repeat EVL every 1-4 weeks until variceal eradication 1, 2
    • After eradication, perform surveillance endoscopy at 1-3 months and then every 6-12 months to check for recurrence 1
  3. Rescue Therapy for Rebleeding

    • TIPS should be considered in Child-Pugh A or B patients who experience recurrent variceal hemorrhage despite combination therapy 1
    • In centers with expertise, surgical shunts can be considered for Child-Pugh A patients 1

Pre-emptive TIPS

For high-risk patients (Child-Pugh C ≤13 or Child-Pugh B >7 with active bleeding at endoscopy despite vasoactive agents), pre-emptive TIPS within 72 hours (preferably within 24 hours) should be considered 2

Special Considerations

Portal Vein Thrombosis

  • Portal vein thrombosis may complicate management and negatively impact survival 1
  • TIPS may still be feasible in selected cases with portal vein thrombosis 1

Advanced Liver Disease

  • Patients with high MELD scores (>19) have poor outcomes with TIPS 1
  • Liver transplantation should be considered for eligible patients 1

Common Pitfalls to Avoid

  1. Delayed endoscopy - Perform endoscopy within 12 hours of presentation after hemodynamic stabilization
  2. Inadequate pharmacological therapy - Continue vasoactive drugs for up to 5 days
  3. Combining EVL with sclerotherapy - This increases complications without improving outcomes 1
  4. Insufficient follow-up - Regular endoscopic surveillance is essential to detect and treat recurrent varices
  5. Overuse of TIPS - Reserve for treatment failures or high-risk patients, as it increases encephalopathy risk 1

The management of esophageal varices has significantly improved over the past decades, with combination pharmacological and endoscopic therapy providing effective control of bleeding and reducing mortality in most patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.